Psychosomatic aspects of hyperprolactinemia.

Area of Science:

• Psychoneuroendocrinology
• Reproductive endocrinology
• Behavioral medicine

Background:

• Hyperprolactinemia, elevated prolactin levels, is associated with various symptoms.
• The psychosomatic and behavioral effects of hyperprolactinemia require further investigation.
• Gender differences in the manifestation of hyperprolactinemia's psychological effects are noted.

Purpose of the Study:

• To review recent studies on the psychosomatic aspects of hyperprolactinemia.
• To explore gender-specific behavioral and psychological effects of elevated prolactin.
• To assess the impact of hyperprolactinemia on mood, hostility, and libido.

Main Methods:

• Review of existing literature on hyperprolactinemia and its psychological correlates.
• Comparison of self-reported psychological distress in hyperprolactinemic individuals versus control groups.
• Assessment of symptom changes following bromocriptine treatment.

Main Results:

• Women with hyperprolactinemia exhibit higher levels of hostility, depression, and anxiety compared to controls.
• Hyperprolactinemic males do not show increased hostility or depression.
• Psychological distress and hostility in hyperprolactinemic patients often improve with bromocriptine treatment.
• Postpartum patients with similar prolactin levels show less depression and anxiety than hyperprolactinemic women.
• Hostility, depression, and loss of libido can occur independently or concurrently in hyperprolactinemia.

Conclusions:

• Hyperprolactinemia disproportionately affects women's psychological well-being, manifesting as increased hostility, depression, and anxiety.
• Treatment with bromocriptine can alleviate psychological distress and hostility associated with hyperprolactinemia.
• The psychosomatic impact of hyperprolactinemia is complex and may involve independent or coexisting symptoms like hostility, depression, and reduced libido.